These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23782082)

  • 1. Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.
    Elliott BM; Aledort LM
    Expert Rev Hematol; 2013 Jun; 6(3):277-86. PubMed ID: 23782082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate?
    Cushing MM; Haas T; Karkouti K; Callum J
    Transfusion; 2020 Jun; 60 Suppl 3():S17-S23. PubMed ID: 32478877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical evaluation of cryoprecipitate for replacement of fibrinogen.
    Sørensen B; Bevan D
    Br J Haematol; 2010 Jun; 149(6):834-43. PubMed ID: 20456356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemia.
    Idris SF; Hadjinicolaou AV; Sweeney M; Winthrop C; Balendran G; Besser M
    Br J Haematol; 2014 Aug; 166(3):458-61. PubMed ID: 24725203
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.
    Levy JH; Welsby I; Goodnough LT
    Transfusion; 2014 May; 54(5):1389-405; quiz 1388. PubMed ID: 24117955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro efficacy of RiaSTAP after rapid reconstitution.
    Karri JV; Cardenas JC; Johansson PI; Matijevic N; Cotton BA; Wade CE; Holcomb JB
    J Surg Res; 2014 Aug; 190(2):655-61. PubMed ID: 24602482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Whether fibrinogen concentrates are necessary in Russia?].
    Galstian GM; Berkovskiĭ AL; Zhuravlev VV; Polokhov DM; Savchenko VG
    Anesteziol Reanimatol; 2014; (3):49-59. PubMed ID: 25306685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial.
    Galas FR; de Almeida JP; Fukushima JT; Vincent JL; Osawa EA; Zeferino S; Câmara L; Guimarães VA; Jatene MB; Hajjar LA
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1647-55. PubMed ID: 24951020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cryoprecipitate: that old unknown.
    Blasi A; Beltran J; Pereira A; Puig L
    Rev Esp Anestesiol Reanim; 2015 Apr; 62(4):204-12. PubMed ID: 25561426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoprecipitate. Patterns of use.
    Pantanowitz L; Kruskall MS; Uhl L
    Am J Clin Pathol; 2003 Jun; 119(6):874-81. PubMed ID: 12817436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
    Yamamoto K
    Rinsho Byori; 2011 Jul; 59(7):678-83. PubMed ID: 21874794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of afibrinogenemia in a chihuahua.
    Chambers G
    J Am Anim Hosp Assoc; 2013; 49(1):70-4. PubMed ID: 23148136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen concentrate for acquired hypofibrinogenaemic states.
    Weinkove R; Rangarajan S
    Transfus Med; 2008 Jun; 18(3):151-7. PubMed ID: 18598277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cryoprecipitate in human and canine transfusion medicine.
    Prittie J
    J Vet Emerg Crit Care (San Antonio); 2021 Mar; 31(2):204-214. PubMed ID: 33751762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial.
    Karkouti K; Callum J; Rao V; Heddle N; Farkouh ME; Crowther MA; Scales DC
    BMJ Open; 2018 Apr; 8(4):e020741. PubMed ID: 29678987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients.
    Abrahamyan L; Tomlinson G; Callum J; Carcone S; Grewal D; Bartoszko J; Krahn M; Karkouti K
    JAMA Surg; 2023 Mar; 158(3):245-253. PubMed ID: 36598773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
    Bevan DH
    Thromb Res; 2009 Dec; 124 Suppl 2():S12-6. PubMed ID: 20109651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen concentrate--a potential universal hemostatic agent.
    Fenger-Eriksen C; Ingerslev J; Sørensen B
    Expert Opin Biol Ther; 2009 Oct; 9(10):1325-33. PubMed ID: 19645632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.